Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Cytorex Biosciences completes cytotoxicity testing with Cytoreg

July 14, 2004

Inhibitors of receptor tyrosine kinases claimed by Array BioPharma

July 13, 2004

Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth

July 13, 2004

Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma

July 13, 2004

Abbott plans Xinlay NDA filing later this year

July 13, 2004

Antagonists of antiapoptotic protein for the treatment of cancer

July 12, 2004

Bayer describes agents for hyperproliferative disorders

July 12, 2004

Silicon compounds for GnRH related disorders

July 12, 2004

Lorus expands Canadian prostate cancer study of GTI-2501 and docetaxel

July 12, 2004

Enrollment open at European sites in CoFactor phase II study

July 12, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...